hgh vs hgh frag 176-191

updated October 25, 2026

hgh (tier S) vs hgh frag 176-191 (tier C): what each is, why each got its grade, half-life and source counts side by side.

hgh · tier S

growth hormone. banned in sports, standard at every anti-aging clinic, expensive. works, with trade-offs.

tier rationale

the original anabolic peptide drug. 40+ years of FDA approval across 11+ brand names for pediatric growth failure, adult GHD, HIV wasting, and short bowel syndrome. massive evidence base. criminalized for non-approved uses. one of the most regulated peptides in existence. four decades of pivotal trial evidence. S is the only defensible tier.

hgh frag 176-191 · tier C

HGH fragment 176-191. sold as 'fat loss without growth.' the AOD9604 trial that tested this idea failed.

tier rationale

C-tier because the compound has a plausible mechanistic rationale, a genuine research origin at Monash, but the clinical evidence story is not favorable: the modified version (AOD9604) that actually went to Phase 2b failed to produce meaningful weight loss, and the unmodified 176-191 fragment that grey-market vendors sell has even less specific human data. Community reports are split roughly between 'noticeable fat loss during cut cycles' and 'no detectable effect', a bimodal distribution that's hard to reconcile with a consistent pharmacological effect. Not B-tier because the clinical evidence clearly doesn't support the claims. Not D-tier because the compound isn't a marketing invention, it has real research origins and at least partial in vitro and preclinical support for the mechanistic claim.

at a glance

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.